IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Swine flu, the bioterrorist of 21st century and role of pharmacist To fight against it.

Author: UPLOADED BY-ADMIN, N. A. SINGHAL, S. M. VIJAYENDRA SWAMY
Abstract: Swine flu is more dangerous than terrorist because it can affect the life of general people and kill more people in period of last three month than those who can affected by terrorists attack. So in order to define Swine flu the word “BIO TERRORIST” is most appropriate for it. On 11th June 2009, World Health Organization (WHO) declared influenza A (H1N1), also known as swine flu, as a pandemic. As per WHO report, there are more than 177457cases of infection, including 1462 deaths till 6th August-2009 across the world. In India, till 16th August 2009, about 1556 positive cases of H1N1 with Twenty Five deaths were recorded, was still in the early days of the outbreak. Like other influenza, Swine flu virus also able to produce human to human transmissions and as a result WHO predicted that, the swine flu virus will infect a third of the world's population if it continues to spread at its current rate. As a pharmacist, we know that people who have contracted the new A (H1N1) virus have experienced influenza-like symptoms (such as sore throat, cough, runny nose, fever, malaise, headache, joint/muscle pain) and recovered by using antiviral drugs. An antiviral drug for influenza is inhibitor of neuraminidase such as Oseltamivir and Zanamivir. Proper use of drugs and to prevent development of resistance towards virus is in hand of pharmacist. Pharmacist knows that Vaccine is the useful tool to fight against such an infectious disease, even though till dates no vaccine available in market. Other preventive measures include drugs; social distancing and personal hygiene can also help to control such disease.
Keyword: Influenza A (H1N1), human-to-human transmission, antiviral, vaccine.
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus